Penn State medical researchers have found that calcium phosphate nanocomposite particles (CPNPs)encapsulating cancer-killing ceramide (effectively making ceramide soluble), killed 95 percent of human melanoma cells and were “highly effective” against human melanoma and breast cancer cells that are normally resistant to anticancer drugs.